Skinvisible, Inc. announced a private placement that it has issued a total of 350,000 units to accredited investors, where each unit was priced at $0.10 per unit for the gross proceeds of $35,000 on June 4, 2024. Each unit consists of one share of common stock in the company and a warrant to purchase one-half of one share of common stock in the company, exercisable for one year from issuance with an exercise price at $0.20 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7499 USD | 0.00% |
|
+19.03% | +794.87% |
06-04 | Skinvisible, Inc. announced that it has received $0.035 million in funding | CI |
05-15 | Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+794.87% | 3.67M | |
+12.54% | 389B | |
+14.34% | 137B | |
-7.06% | 69.77B | |
-27.25% | 38.15B | |
-15.56% | 34.81B | |
+0.63% | 32.75B | |
+8.56% | 17.97B | |
+21.63% | 16.88B | |
+7.81% | 12.77B |
- Stock Market
- Equities
- SKVI Stock
- News Skinvisible, Inc.
- Skinvisible, Inc. announced that it has received $0.035 million in funding